Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 18;33(7):660-669.
doi: 10.1093/ajh/hpaa070.

Associations of Maternal Early-Pregnancy Glucose Concentrations With Placental Hemodynamics, Blood Pressure, and Gestational Hypertensive Disorders

Affiliations

Associations of Maternal Early-Pregnancy Glucose Concentrations With Placental Hemodynamics, Blood Pressure, and Gestational Hypertensive Disorders

Jan S Erkamp et al. Am J Hypertens. .

Abstract

Background: Gestational diabetes mellitus is associated with increased risks of gestational hypertension and preeclampsia. We hypothesized that high maternal glucose concentrations in early pregnancy are associated with adverse placental adaptations and subsequently altered uteroplacental hemodynamics during pregnancy, predisposing to an increased risk of gestational hypertensive disorders.

Methods: In a population-based prospective cohort study from early pregnancy onwards, among 6,078 pregnant women, maternal early-pregnancy non-fasting glucose concentrations were measured. Mid and late pregnancy uterine and umbilical artery resistance indices were assessed by Doppler ultrasound. Maternal blood pressure was measured in early, mid, and late pregnancy and the occurrence of gestational hypertensive disorders was assessed using hospital registries.

Results: Maternal early-pregnancy glucose concentrations were not associated with mid or late pregnancy placental hemodynamic markers. A 1 mmol/l increase in maternal early-pregnancy glucose concentrations was associated with 0.71 mm Hg (95% confidence interval 0.22-1.22) and 0.48 mm Hg (95% confidence interval 0.10-0.86) higher systolic and diastolic blood pressure in early pregnancy, respectively, but not with blood pressure in later pregnancy. Also, maternal glucose concentrations were not associated with the risks of gestational hypertension or preeclampsia.

Conclusions: Maternal early-pregnancy non-fasting glucose concentrations within the normal range are associated with blood pressure in early pregnancy, but do not seem to affect placental hemodynamics and the risks of gestational hypertensive disorders.

Keywords: Doppler; blood pressure; cohort; gestational hypertensive disorders; glucose; hypertension; placenta; pregnancy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flowchart population for analysis.
Figure 2.
Figure 2.
Longitudinal associations between tertiles of early-pregnancy glucose concentrations and blood pressure (n = 6,078). Blood pressure patterns in different maternal early-pregnancy glucose tertiles. (a) Systolic and (b) diastolic blood pressure in different maternal early-pregnancy glucose tertiles (n = 6,078). Results reflect the change in mm Hg in mothers with early-pregnancy glucose concentrations in the second (4.0–4.6 mmol/l) and third (4.6–10.3 mmol/l) tertiles, compared with those with glucose levels in the first tertile (0.3–4.0 mmol/l). (a) Systolic blood pressure = β0 + β1 × glucose tertile + β2 × gestational age + β3 × gestational age−2 + β4 × glucose tertile × gestational age. (b) Diastolic blood pressure = β0 + β1 × glucose tertile + β2 × gestational age + β3 × gestational age0.5 + β4 × glucose tertile × gestational age. The models were adjusted for gestational age at intake. The interaction term of maternal early-pregnancy glucose tertile with gestational age in weeks was not significant. Similarly, when glucose was used continuously in the models, no significant interaction of maternal early-pregnancy glucose concentration with gestational age in weeks was observed. Estimates are given in Supplementary Table S5 online.

References

    1. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 2007; 30(Suppl 2):S141–S146. - PubMed
    1. Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, Persson B, Hod M, Oats JJ; Group HSCR . The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 2012; 35:780–786. - PMC - PubMed
    1. Cvitic S, Desoye G, Hiden U. Glucose, insulin, and oxygen interplay in placental hypervascularisation in diabetes mellitus. Biomed Res Int 2014; 2014:145846. - PMC - PubMed
    1. Vega M, Mauro M, Williams Z. Direct toxicity of insulin on the human placenta and protection by metformin. Fertil Steril 2019; 111:489–496.e5. - PubMed
    1. Lowe LP, Metzger BE, LoweWL, Jr., Dyer AR, McDade TW, McIntyre HD; Group HSCR . Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. J Clin Endocrinol Metab 2010; 95:5427–5434. - PMC - PubMed

Publication types